Drastic action is considered essential, but this is part of a wider strategy that represents a looming calamity for Stormont ...

The UK’s life sciences sector will receive £279 million from drugs giant Eli Lilly, to invest in developing new medicines and ways to deliver treatment. “The long-term benefits of these drugs could be ...

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

"These are not case-specific issues," the plaintiffs contended. "The marketing was national in scale and magnitude, and ...

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

Severe malnutrition is treated with ready-to-use therapeutic food, a paste combining peanuts, sugar, milk powder, oil, ...

Eli Lilly’s senior VP of information and R&D IT, Ramesh Durvasula, said Lilly will use AI and tech to transform the company.

Eighty states, cities, counties, school boards and unions have joined litigation in a New Jersey district court against the three major pharmacy middlemen.

Adam Green, chief executive of unemployment charity Yes Manchester, said obesity was low on the list of reasons why some ...

Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.

“ (Weight loss medications) can help, for sure, but exercise and getting enough protein to make sure you aren’t losing muscle ...

Eli Lilly has announced a strategic collaboration with UK government departments to address population health challenges, ...